|
|
News Breaks | | | | September 13, 2012 | | 05:30 EDT |  | NABI | Nabi shareholders urged to voist against Nabi/Biota merger by ISS, Glass Lewis
The Mangrove Partners Fund, L.P., one of the largest stockholders of Nabi Biopharmaceuticals, announced that both Institutional Shareholder Services, or ISS, and Glass Lewis & Co. have recommended that stockholders support Mangrove Partners and vote against the proposed merger of Nabi with Biota Holdings Ltd. Both preeminent proxy advisory firms supported Mangrove Partners' view that the proposed Transaction does not deliver adequate value to Nabi stockholders and both advise stockholders to vote AGAINST all six management proposals in connection with the Transaction at the special meeting of stockholders scheduled to be held on Sept. 24. | |
|
News For NABI From The Last 14 Days Check below for free stories on NABI the last two weeks. |
|
|
| There are no results for NABI |
|
|
|
|
|
|
